Conserved allomorphs of MR1 drive the specificity of MR1-restricted TCRs.
Saved in:
| Title: | Conserved allomorphs of MR1 drive the specificity of MR1-restricted TCRs. |
|---|---|
| Authors: | Cornforth TV; Enara Bio Ltd., Oxford, United Kingdom., Moyo N; Enara Bio Ltd., Oxford, United Kingdom., Cole S; Enara Bio Ltd., Oxford, United Kingdom., Lam EPS; Enara Bio Ltd., Oxford, United Kingdom., Lobry T; Enara Bio Ltd., Oxford, United Kingdom., Wolchinsky R; Enara Bio Ltd., Oxford, United Kingdom., Lloyd A; Enara Bio Ltd., Oxford, United Kingdom., Ward K; Enara Bio Ltd., Oxford, United Kingdom., Denham EM; Enara Bio Ltd., Oxford, United Kingdom., Masi G; Enara Bio Ltd., Oxford, United Kingdom., Qing Yun PT; Enara Bio Ltd., Oxford, United Kingdom., Moore C; Enara Bio Ltd., Oxford, United Kingdom., Dhaouadi S; Enara Bio Ltd., Oxford, United Kingdom., Besra GS; Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, Birmingham, United Kingdom., Veerapen N; Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, Birmingham, United Kingdom., Illing PT; Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia., Vivian JP; Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia., Raynes JM; Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia., Le Nours J; Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia., Purcell AW; Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia., Kundu S; Enara Bio Ltd., Oxford, United Kingdom., Silk JD; Enara Bio Ltd., Oxford, United Kingdom., Williams L; Enara Bio Ltd., Oxford, United Kingdom., Papa S; Enara Bio Ltd., Oxford, United Kingdom.; School of Cancer and Pharmaceutical Sciences, King's College London, Guy's Hospital, London, United Kingdom., Rossjohn J; Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.; Institute of Infection and Immunity, Cardiff University, School of Medicine, Cardiff, United Kingdom., Howie D; Enara Bio Ltd., Oxford, United Kingdom., Dukes J; Enara Bio Ltd., Oxford, United Kingdom. |
| Source: | Frontiers in oncology [Front Oncol] 2024 Oct 03; Vol. 14, pp. 1419528. Date of Electronic Publication: 2024 Oct 03 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
